14 stories found
The co-founders and top executives of Germany's BioNTech, known for its COVID-19 vaccine, will leave the company by the end of 2026 to establish a new venture, following a billion-euro loss.
Sahin und Türeci waren die Gesichter von Biontech - dem Unternehmen, das mit dem Partner Pfizer die erste Zulassung für einen Corona-Impfstoff bekam. Nun wagt das Forscher-Ehepaar noch einmal Neues.
BioNTech sues Moderna for patent infringement over COVID shots Reuters
The Turkish co-founders of BioNTech are leaving the company to establish a new enterprise focused on next-generation mRNA technology. This move comes as BioNTech continues to record significant achievements.
The founders of Biontech, known for their COVID-19 vaccine, are reportedly leaving the company to establish a new venture.
BioNTech SE (BNTX) is experiencing a rally in its stock due to a solid oncology strategy.
Uğur Şahin and Özlem Türeci, the founding couple of BioNTech, are leaving the German vaccine manufacturer to establish a new firm focused on mRNA research, as BioNTech faces significant financial losses.
Uğur Şahin and Özlem Türeci, the co-founders of BioNTech, are stepping down from the German pharmaceutical company to pursue a new venture in mRNA technology.
Moderna is facing a lawsuit alleging that its COVID-19 vaccine violates a patent linked to the Pfizer/BioNTech shot.